CEBPG-TDRD12 Fusion FISH Probe
The CEBPG-TDRD12 Fusion FISH Probe is used to confirm a fusion of the CEBPG and TDRD12 genes. The fusion of the CEBPG and TDRD12 genes has been associated with Bladder Urothelial Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CEBPG-TDRD12-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CEBPG-TDRD12-20-AQAQ | 20 (40 μL) | 200 μL |
|
CEBPG Gene Summary
The C/EBP family of transcription factors regulates viral and cellular CCAAT/enhancer element-mediated transcription. C/EBP proteins contain the bZIP region, which is characterized by two motifs in the C-terminal half of the protein: a basic region involved in DNA binding and a leucine zipper motif involved in dimerization. The C/EBP family consist of several related proteins, C/EBP alpha, C/EBP beta, C/EBP gamma, and C/EBP delta, that form homodimers and that form heterodimers with each other. CCAAT/enhancer binding protein gamma may cooperate with Fos to bind PRE-I enhancer elements. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Nov 2011]
Gene Name: CCAAT/enhancer Binding Protein Gamma
Chromosome: CHR19: 33864608 -33873592
Locus: 19q13.11
TDRD12 Gene Summary
The Tudor Domain Containing 12 (TDRD12) gene is located on chr19 :33210678-33281714 at 19q13.11.
Gene Name: Tudor Domain Containing 12
Chromosome: CHR19: 33210678 -33281714
Locus: 19q13.11
Gene Diseases
The CEBPG TDRD12 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Bladder Urothelial Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|